Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.

A team of Vanderbilt employees have received and award for implementing a streamlined follow-up protocol for patients who may not know they have cancer.

Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure.

Vanderbilt researchers are examining the effect of time of day on COVID test accuracy.

Vanderbilt research is raising new questions about the long-term benefit and value of the so-called Medicare “Two-Midnight Rule” implemented in 2013 to reduce costly and potentially unnecessary inpatient hospital admissions